Compare ZH & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZH | LENZ |
|---|---|---|
| Founded | 2011 | 2019 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.1M | 278.4M |
| IPO Year | 2021 | 2021 |
| Metric | ZH | LENZ |
|---|---|---|
| Price | $2.90 | $7.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | 161.0K | ★ 853.7K |
| Earning Date | 05-26-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,088,000.00 |
| Revenue This Year | N/A | $50.42 |
| Revenue Next Year | N/A | $197.16 |
| P/E Ratio | $20.74 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.57 | $6.61 |
| 52 Week High | $5.55 | $50.19 |
| Indicator | ZH | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 31.82 | 44.69 |
| Support Level | $2.57 | $6.61 |
| Resistance Level | $3.45 | $10.42 |
| Average True Range (ATR) | 0.11 | 0.64 |
| MACD | -0.03 | 0.08 |
| Stochastic Oscillator | 6.52 | 34.13 |
Zhihu Inc is engaged in the operation of one online content community which monetizes through paid membership services, marketing services and other services in the People's Republic of China. It is an online content community where people come to find solutions, make decisions, seek inspiration, and have fun. Its community supports discussions ranging from everyday consumer decisions, such as purchasing products or planning travel, to more specialized areas on professional knowledge, technological developments including artificial intelligence and academic topics. It operates in single segment and its revenues are derived from within the PRC.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.